TDO2 and cancer: By activating the Wnt5a pathway, TDO2 has been shown by Hui Liu et al. 65 to influence the expression of cancer-related biomarkers such as matrix metalloproteinase 7 (MMP7) and cell adhesion receptor CD44, which facilitates the migration and invasion of cancer cells.